Historical Valuation
Envoy Medical Inc (COCH) is now in the Fair zone, suggesting that its current forward PS ratio of 95.37 is considered Fairly compared with the five-year average of -1.83. The fair price of Envoy Medical Inc (COCH) is between 0.10 to 1.18 according to relative valuation methord.
Relative Value
Fair Zone
0.10-1.18
Current Price：0.69
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Envoy Medical Inc (COCH) has a current Price-to-Book (P/B) ratio of -2.20. Compared to its 3-year average P/B ratio of -6.82 , the current P/B ratio is approximately -67.77% higher. Relative to its 5-year average P/B ratio of -6.16, the current P/B ratio is about -64.28% higher. Envoy Medical Inc (COCH) has a Forward Free Cash Flow (FCF) yield of approximately -85.29%. Compared to its 3-year average FCF yield of -53.65%, the current FCF yield is approximately 58.97% lower. Relative to its 5-year average FCF yield of -53.65% , the current FCF yield is about 58.97% lower.
P/B
Median3y
-6.82
Median5y
-6.16
FCF Yield
Median3y
-53.65
Median5y
-53.65
Competitors Valuation Multiple
AI Analysis for COCH
The average P/S ratio for COCH competitors is 16.17, providing a benchmark for relative valuation. Envoy Medical Inc Corp (COCH.O) exhibits a P/S ratio of 95.37, which is 489.73% above the industry average. Given its robust revenue growth of -25.00%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for COCH
1Y
3Y
5Y
Market capitalization of COCH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of COCH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is COCH currently overvalued or undervalued?
Envoy Medical Inc (COCH) is now in the Fair zone, suggesting that its current forward PS ratio of 95.37 is considered Fairly compared with the five-year average of -1.83. The fair price of Envoy Medical Inc (COCH) is between 0.10 to 1.18 according to relative valuation methord.
What is Envoy Medical Inc (COCH) fair value?
COCH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Envoy Medical Inc (COCH) is between 0.10 to 1.18 according to relative valuation methord.
How does COCH's valuation metrics compare to the industry average?
The average P/S ratio for COCH's competitors is 16.17, providing a benchmark for relative valuation. Envoy Medical Inc Corp (COCH) exhibits a P/S ratio of 95.37, which is 489.73% above the industry average. Given its robust revenue growth of -25.00%, this premium appears unsustainable.
What is the current P/B ratio for Envoy Medical Inc (COCH) as of Jan 10 2026?
As of Jan 10 2026, Envoy Medical Inc (COCH) has a P/B ratio of -2.20. This indicates that the market values COCH at -2.20 times its book value.
What is the current FCF Yield for Envoy Medical Inc (COCH) as of Jan 10 2026?
As of Jan 10 2026, Envoy Medical Inc (COCH) has a FCF Yield of -85.29%. This means that for every dollar of Envoy Medical Inc’s market capitalization, the company generates -85.29 cents in free cash flow.
What is the current Forward P/E ratio for Envoy Medical Inc (COCH) as of Jan 10 2026?
As of Jan 10 2026, Envoy Medical Inc (COCH) has a Forward P/E ratio of -0.65. This means the market is willing to pay $-0.65 for every dollar of Envoy Medical Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Envoy Medical Inc (COCH) as of Jan 10 2026?
As of Jan 10 2026, Envoy Medical Inc (COCH) has a Forward P/S ratio of 95.37. This means the market is valuing COCH at $95.37 for every dollar of expected revenue over the next 12 months.